Nexium IV (esomeprazole sodium)

Published Online: Tuesday, November 1, 2005

AstraZeneca (Wilmington, Del) recently received FDA approval for Nexium IV for injection. The product is indicated for intravenous (IV) infusion or injection for the short-term treatment (up to 10 days) of gastroesophageal reflux disease in patients with a history of erosive esophagitis who are unable to take capsules. The recommended adult dosage regimen for the product is either 20 or 40 mg of Nexium IV given once daily by IV injection (=3 minutes) or IV infusion (10 to 30 minutes). Nexium IV is supplied as a freeze-dried powder containing 20 or 40 mg of esomeprazole per single-use vial. For more information, visit www.nexium-us.com, or call 800-237-8898.




Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues
$auto_registration$
VSEO N/A